email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
2101 - 2115
of 3612 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Fosun to Pay up to $148 Million for China Rights to MimiVax Glioblastoma Treatment
$5.00
Available
GenScript Forms Bispecific Partnership with Korea's ABL Bio
$5.00
Available
BeiGene BTK Cancer Drug Approved in US for Lymphoma
$5.00
Available
Everest Starts China Phase III Trial of Ulcerative Colitis Treatment
$5.00
Available
BeiGene's PD-1 Recommended for Approval by China's CDE
$5.00
Available
Chi-Med's NDA for Surufatinib Accepted by China's NMPA for Review
$5.00
Available
Shanghai Anovent Closes Funding Led by Sequoia for Respiratory Drugs
$5.00
Available
Aslan's Varlitinib Fails to Meet Goals in Phase III Trial
$5.00
Available
Hua Reports Positive Phase III Data for Novel Type 2 Diabetes Drug
$5.00
Available
Leo Pharma Licenses Novel Dermatology Molecules Discovered by HitGen
$5.00
Available
TenNor Announces Positive Results from US Trial of Novel Anti-bacterial
$5.00
Available
Akeso Presents Positive Trial Results from PD-1/CTLA-4 Candidate
$5.00
Available
Tot Biopharm Completes $66.5 Million Hong Kong IPO
$5.00
Available
Antengene Acquires Global Rights to AstraZeneca Cancer Candidate
$5.00
Available
Bio-Thera Approved to Launch Humira Biosimilar in China
$5.00
Available